Brought to you by 
TriVascular brings in $60mm through its Series C round
Jul 2010
Executive Summary
TriVascular Inc. (stents for endovascular aortic repair) has raised $60mm through its Series C venture round. New backer Pinnacle Ventures led the financing and was joined by current shareholders New Enterprise Associates, Delphi Ventures, MPM Capital, and Kearny Venture Partners. Pinnacle and NEA will each contribute one board member. The money will support the launch TriVascular's Ovation abdominal stent graft system in Europe, clinical research performed on three continents for projects that include the Ovation thoracic stent graft system, and next-generation product development. The company has brought in $155mm since it was restarted in 2008 after being acquired from Boston Scientific.
Deal Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TriVascular brings in $60mm through its Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice